{"id":951986,"date":"2026-04-16T09:02:15","date_gmt":"2026-04-16T13:02:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/"},"modified":"2026-04-16T09:02:15","modified_gmt":"2026-04-16T13:02:15","slug":"korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/","title":{"rendered":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li>\n          <strong>American Society of Gene and Cell Therapy 29<sup>th<\/sup> Annual Meeting (ASGCT) <\/strong>\n        <\/li>\n<li>\n          <strong>TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference<\/strong>\n        <\/li>\n<li>\n          <strong>3<sup>rd<\/sup> International Conference on Ureagenesis Defects and Allied Conditions<\/strong>\n        <\/li>\n<li>\n          <strong>European Association for the Study of the Liver (EASL) Congress 2026\u00a0 \u00a0\u00a0<\/strong>\n        <\/li>\n<\/ul>\n<p align=\"justify\">CAMBRIDGE, Mass., April  16, 2026  (GLOBE NEWSWIRE) &#8212; Korro, Bio, Inc. (Korro) (Nasdaq: KRRO),\u00a0 a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced oral and poster presentations highlighting data from its oligonucleotide delivery based RNA editing technology (OPERA<sup>\u00ae<\/sup>) will take place at the following scientific conferences:<\/p>\n<p align=\"justify\">\n        <strong>3<sup>rd<\/sup> International Conference on Ureagenesis Defects and Allied Conditions, April 22-24 in Pozzuoli, Italy<\/strong>\n      <\/p>\n<p>\n        <strong>Oral presentation title: <\/strong>KRRO-121, a GalNAc-conjugated oligonucleotide stabilizing Glutamine Synthetase, demonstrates robust ammonia clearance in preclinical hyperammonemia models<br \/><strong>Speaker:<\/strong> Maria Dafne Cardamone, Ph.D, Associate Director, Biology, Korro Bio, Inc.<br \/><strong>Date\/Time:<\/strong> April 24, 2026, 9:25 AM \u2013 9:50 AM CEST<\/p>\n<p align=\"justify\">\n        <strong>American Society of Gene and Cell Therapy 29<sup>th<\/sup> Annual Meeting (ASGCT), May 11-15 in Boston, MA<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Oral presentation title: <\/strong>KRRO-121, a GalNAc-conjugated oligonucleotide modulating glutamine synthetase, demonstrates robust ammonia clearance and potential to treat hyperammonemia in preclinical model systems<br \/><strong>Speaker: Todd Chappell, Chief Operating Officer, <\/strong>Korro Bio, Inc.<br \/><strong>Date\/Time: <\/strong>May 14, 2026<strong>, <\/strong>3:45-4:00 PM EST<br \/><strong>Session\/Track<\/strong>: Programmable Epigenetic and RNA Editing for Precision Regulation<\/p>\n<p align=\"justify\">\n        <strong>Oral presentation title:<\/strong> A GalNAc-conjugated RNA editing oligonucleotide achieves &gt;90% editing of pathogenic SERPINA1 transcripts, restoring Alpha-1 Antitrypsin function in AATD models<br \/><strong>Speaker: Tyson Moyer, Ph.D, <\/strong>Associate Director, Biology, Korro Bio, Inc.<br \/><strong>Date\/Time: <\/strong>May 15, 2026<strong>, <\/strong>4:30-4:45 PM EST<br \/><strong>Session\/Track<\/strong>: Expanding Cell and Gene Therapy Through Therapeutic RNA and Epigenome Engineering<\/p>\n<p align=\"justify\">\n        <strong>Poster presentation title:<\/strong> RNA Editing of TARDBP reduces TDP-43 aggregation while restoring its nuclear localization and splicing function in ALS disease models<br \/><strong>Name: Leah Liu, <\/strong>Ph.D, Director, Biology, Korro Bio, Inc.<br \/><strong>Poster Number: <\/strong>1314<br \/><strong>Date\/Time: <\/strong>May 12, 2026<strong>, <\/strong>5-6:30 PM EST<br \/><strong>Session\/Track<\/strong>: Welcome and Poster Reception<\/p>\n<p align=\"justify\">\n        <strong>Poster presentation title:<\/strong> Novel triplet chemistries informed by structural biology expand OPERA\u00ae platform capabilities<br \/><strong>Name: Adam Hedger, Ph.D, Scientist II, Medicinal Chemistry, <\/strong>Korro Bio, Inc.<br \/><strong>Poster Number: <\/strong>2313<br \/><strong>Date\/Time: <\/strong>May 13, 2026<strong>, <\/strong>5-6:30 PM EST<br \/><strong>Session\/Track<\/strong>: Poster Reception<\/p>\n<p align=\"justify\">\n        <strong>TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference, May 11-14 in Boston, MA<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Podium presentation title: <\/strong>Precision RNA editing at scale: platform innovations generating product candidates<br \/><strong>Speaker:<\/strong> Lo\u00efc Vincent, Ph.D, Chief Scientific Officer, Korro Bio, Inc.<br \/><strong>Date\/Time:<\/strong> May 14, 2026, 9:30-10:00 AM EST<br \/><strong>Session\/Track<\/strong>: Oligonucleotide Discovery, Preclinical and Clinical<\/p>\n<p align=\"justify\">\n        <strong>EASL Congress 2026: May 27-30 in Barcelona, Spain<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Poster presentation title: <\/strong>Uncontrolled Ammonia is Associated with Increased Healthcare Resource Utilization in Hepatic Encephalopathy<br \/><strong>Name:<\/strong> Jonathan T. Fischer, Ph.D, Senior Manager, Strategy and Portfolio Planning<strong>,\u00a0<\/strong>Korro Bio, Inc.<br \/><strong>Poster Number:<\/strong> WED-441<br \/><strong>Date\/ Time:\u00a0<\/strong>May 25, 2026, 8:30AM \u2013 5:00 PM CET (poster)<br \/><strong>Session\/Track<\/strong>: Cirrhosis and Its Complications: Other Clinical Complications Except ACLF and Critical Illness<\/p>\n<p align=\"justify\">\n        <strong>About Korro <\/strong>\n      <\/p>\n<p align=\"justify\">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases. Korro is generating a portfolio of differentiated programs that are designed to harness the body\u2019s natural RNA editing process, enabling a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com.<\/p>\n<p align=\"justify\">Korro intends to use its Investor Relations website, LinkedIn, and X (Twitter) as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Korro\u2019s Investor Relations website and follow @KorroBio on LinkedIn, and X (Twitter), in addition to following Korro\u2019s press releases, SEC filings, public conference calls, presentations, and webcasts.<\/p>\n<p align=\"justify\">\n        <strong>Korro Bio Contact Information<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Investor &amp; Media Contact<\/strong><br \/>\n        <br \/>Malini Chatterjee, Ph.D<br \/>Blueprint Life Science Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5p4-qudCqyl0_U1rIi3nekXFWKBwXrC_oqOTCKWRC2upBwkTCCON-kDi76OAfxatnaQ_JQIozzV6g-kYDnbMGN_hWQMSWurn4LyF2mAdQYqmru4wN_0CAToowyd3psJ2\" rel=\"nofollow\" target=\"_blank\">mchatterjee@bplifescience.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=45KweqOERHcniMdb309J56clgsgrWRIwR-E2WdqZhwdCSvIQLum0Vi44aKzqMS8x7YsLirGX4J51oAIGu8ONXwZlf6IroXGjMk554I-YVRM=\" rel=\"nofollow\" target=\"_blank\">ir@korrobio.com<\/a><br \/>917.330.4269<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODY1MmM1MmItYzQ0Ni00YWRiLTgyMGItMDIyZGI5ZDE3N2NjLTEyNzM3NTUtMjAyNi0wNC0xNi1lbg==\/tiny\/Korro-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd International Conference on Ureagenesis Defects and Allied Conditions European Association for the Study of the Liver (EASL) Congress 2026\u00a0 \u00a0\u00a0 CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) &#8212; Korro, Bio, Inc. (Korro) (Nasdaq: KRRO),\u00a0 a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced oral and poster presentations highlighting data from its oligonucleotide delivery based RNA editing technology (OPERA\u00ae) will take place at the following scientific conferences: 3rd International Conference on Ureagenesis Defects and Allied Conditions, April 22-24 in Pozzuoli, Italy Oral presentation title: KRRO-121, a GalNAc-conjugated oligonucleotide &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-951986","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd International Conference on Ureagenesis Defects and Allied Conditions European Association for the Study of the Liver (EASL) Congress 2026\u00a0 \u00a0\u00a0 CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) &#8212; Korro, Bio, Inc. (Korro) (Nasdaq: KRRO),\u00a0 a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced oral and poster presentations highlighting data from its oligonucleotide delivery based RNA editing technology (OPERA\u00ae) will take place at the following scientific conferences: 3rd International Conference on Ureagenesis Defects and Allied Conditions, April 22-24 in Pozzuoli, Italy Oral presentation title: KRRO-121, a GalNAc-conjugated oligonucleotide &hellip; Continue reading &quot;Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-16T13:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences\",\"datePublished\":\"2026-04-16T13:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/\"},\"wordCount\":678,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/\",\"name\":\"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=\",\"datePublished\":\"2026-04-16T13:02:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - Market Newsdesk","og_description":"American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd International Conference on Ureagenesis Defects and Allied Conditions European Association for the Study of the Liver (EASL) Congress 2026\u00a0 \u00a0\u00a0 CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) &#8212; Korro, Bio, Inc. (Korro) (Nasdaq: KRRO),\u00a0 a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced oral and poster presentations highlighting data from its oligonucleotide delivery based RNA editing technology (OPERA\u00ae) will take place at the following scientific conferences: 3rd International Conference on Ureagenesis Defects and Allied Conditions, April 22-24 in Pozzuoli, Italy Oral presentation title: KRRO-121, a GalNAc-conjugated oligonucleotide &hellip; Continue reading \"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-16T13:02:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences","datePublished":"2026-04-16T13:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/"},"wordCount":678,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/","name":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=","datePublished":"2026-04-16T13:02:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTA0NyM3NTM4Nzg4IzIyNjIyMDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/korro-announces-oral-and-poster-presentations-at-upcoming-scientific-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/951986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=951986"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/951986\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=951986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=951986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=951986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}